The store will not work correctly when cookies are disabled.
1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-hexyl-1H-1,2,3-triazole
ID: ALA396110
PubChem CID: 11574159
Max Phase: Preclinical
Molecular Formula: C15H16Cl2F3N3
Molecular Weight: 366.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCc1cn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)nn1
Standard InChI: InChI=1S/C15H16Cl2F3N3/c1-2-3-4-5-6-11-9-23(22-21-11)14-12(16)7-10(8-13(14)17)15(18,19)20/h7-9H,2-6H2,1H3
Standard InChI Key: PKFRRJSAWUWWHN-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
7.1848 1.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9699 1.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9732 2.5931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1866 2.8505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7035 2.1829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8785 2.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4703 2.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6461 2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2319 2.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6480 1.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4709 1.4703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4069 2.1854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5749 2.1486 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.3887 3.0102 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.4334 1.3608 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.8860 0.7574 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.8851 3.6118 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.6360 1.2812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5474 0.4610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2135 -0.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1250 -0.8460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7910 -1.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7025 -2.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 6 1 0
1 2 2 0
9 12 1 0
5 6 1 0
12 13 1 0
12 14 1 0
6 7 2 0
12 15 1 0
2 3 1 0
11 16 1 0
7 8 1 0
7 17 1 0
3 4 2 0
2 18 1 0
8 9 2 0
18 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
5 1 1 0
21 22 1 0
10 11 2 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.21 | Molecular Weight (Monoisotopic): 365.0673 | AlogP: 5.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.22 | CX LogP: 6.37 | CX LogD: 6.37 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.61 | Np Likeness Score: -1.24 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |